Partnering & Licensing

Strong partnerships and licensing agreements with leading scientists, academic centers of excellence, innovative biotech companies and high quality manufacturers are recognized as key to RESprotects development and success. The company has worked diligently to create successful and productive relationships.


Current Partnerships

RESprotect has strong scientific co-operations with the Universities of Dresden, Wien and Leipzig.

  • Fraunhofer Institut für Toxikologie und Experimentelle Medizin (ITEM), Hannover/Germany
  • Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Leipzig/Germany
  • Institut für Tumorbiologie-Krebsforschung, Universität Wien/Austria
  • Biotec/Department of Computing, Technical University Dresden/Germany  
RESprotect partnered with Kwang Dong Pharmaceuticals, Inc., Seoul, South Korea, when out- licensed the RP101 rights for South Korea.